Allergan picks CRO ImageIQ for bladder trial

Allergan has reached out to CRO ImageIQ to support its development of a new treatment for bladder disease, recruiting the imaging specialist to pitch in on a new clinical trial. Allergan's drug, LiRIS, is designed to relieve the symptoms of interstitial cystitis, a bladder disorder that can lead to the formation of lesions. ImageIQ is on board to provide its imaging-enabled electronic data capture technology. Release